Clinical Trials Directory

Trials / Completed

CompletedNCT06096363

Predictors of HFNC Failure in Patients With AHRF Using Echocardiography Parameters

Predictors of High-Flow Nasal Cannula Failure (HFNC) in Patients With Acute Hypoxemic Respiratory Failure (AHRF) Using Echocardiography Parameters

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Queen Mary Hospital, Hong Kong · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Right ventricular dysfunction (RVD) and right ventricular-pulmonary arterial (RV-PA) uncoupling detected by transthoracic echocardiography (TTE) in acute respiratory distress syndrome (ARDS) are associated with poor survival. Early detection of RVD and RV-PA uncoupling in patients with acute hypoxemic respiratory failure (AHRF) may be indicative of worsening and decompensating pulmonary condition which may require escalation of respiratory support. The use of TTE parameters in predicting high-flow nasal cannula (HFNC) failure has not been previously studied. The objective of this study is to identify predictors of HFNC failure by TTE and to compare its performance with the well-established ROX index.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTransthoracic EchocardiographyTransthoracic Echocardiography to look for evidence of right ventricular (RV) dysfunction and right ventricular-pulmonary arterial (RV-PA) uncoupling.

Timeline

Start date
2023-04-28
Primary completion
2024-06-26
Completion
2024-09-01
First posted
2023-10-23
Last updated
2024-10-16

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06096363. Inclusion in this directory is not an endorsement.